Immune tolerance is induced through central and peripheral mechanisms that eliminate or suppress self-reactive immune cells. Central tolerance occurs in the thymus and bone marrow where high-affinity self-reactive T and B cells undergo apoptosis or receptor editing. Peripheral tolerance includes anergy induction, suppression by regulatory T cells (Tregs), and inhibition by receptors like CTLA-4 and PD-1. Tregs expressing the transcription factor FoxP3 are critical for maintaining tolerance and preventing autoimmunity. Failure of these tolerance mechanisms can lead to autoimmune disease.
introduction of adaptive immunity. classification of adaptive immunity, factor affecting it and mechanism of adaptive immunity comparison between adaptive immunity and innate immunity. characteristic of adaptive immunity . cell mediated immune responses immunoglobulins
types of immunoglobulins. functions of immunoglobulins, hypersensitivity reactions
Slideshow is from the University of Michigan Medical
School's M1 Immunology sequence
View additional course materials on Open.Michigan:
openmi.ch/med-M1Immunology
T-Cell Activation
• Concept of immune response
• T cell-mediated immune response
• B cell-mediated immune response
I. Concept of immune response
• A collective and coordinated response to the introduction of foreign substances in an individual mediated by the cells and molecules in the immune system.
II. T cell-mediated immune response
• Cell-mediated immunity is the arm of the adaptive immune response whose role is to combat infection of intracellular pathogens, such as intracellular bacteria (mycobacteria, listeria monocytogens), viruses, protozoa, etc.
introduction of adaptive immunity. classification of adaptive immunity, factor affecting it and mechanism of adaptive immunity comparison between adaptive immunity and innate immunity. characteristic of adaptive immunity . cell mediated immune responses immunoglobulins
types of immunoglobulins. functions of immunoglobulins, hypersensitivity reactions
Slideshow is from the University of Michigan Medical
School's M1 Immunology sequence
View additional course materials on Open.Michigan:
openmi.ch/med-M1Immunology
T-Cell Activation
• Concept of immune response
• T cell-mediated immune response
• B cell-mediated immune response
I. Concept of immune response
• A collective and coordinated response to the introduction of foreign substances in an individual mediated by the cells and molecules in the immune system.
II. T cell-mediated immune response
• Cell-mediated immunity is the arm of the adaptive immune response whose role is to combat infection of intracellular pathogens, such as intracellular bacteria (mycobacteria, listeria monocytogens), viruses, protozoa, etc.
Studying the Adaptive Immune Response - Tools for T & B Cell Research: Host D...QIAGEN
Adaptive immunity, powered by T cells and B cells, provides specific, long-lasting protection of the host from harmful invaders. This slidedeck provides an overview of T cells and B cells and their role in cell-mediated immune responses and antibody responses, respectively, against pathogens. There is also information on tools that enable analysis of T and B cell gene expression and regulation, genotyping and signal transduction pathway activation.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
2. Introduction
● Immunologic tolerance = Unresponsiveness to an antigen that is
induced by previous exposure to that antigen
● Tolerogens = Antigens that induce tolerance
● Immunogens = Antigens that generate immunity
● Tolerance to self antigens (self-tolerance) - Fundamental property of normal immune
system
● Failure of self-tolerance → Autoimmunity
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
3. Overview
Physiopathology of immune tolerance-related diseases influenced by several factor:
● Genetic susceptibility
● Route of exposure
● Antigen dose
● Time of exposure
● Structural characteristics of allergen/antigen
● Co-exposure with stimulators of innate immune response, such as infections or
commensal bacteria
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
4. Overview
● Mechanisms of tolerance eliminate and inactivate lymphocytes that express
high-affinity receptors for self antigens
During generating large and diverse repertoire, some developing T and B cells may
express receptors capable of recognizing normal molecules in that individual (self
antigens)
● Tolerance - antigen specific, from recognition of antigens by individual clones of
lymphocytes
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
5. Overview
● Self-tolerance may be induced in immature self-reactive lymphocytes in
generative lymphoid organs (central tolerance) or in mature lymphocytes in
peripheral sites (peripheral tolerance)
- Central tolerance - Mature naive lymphocytes becomes incapable of responding to
self antigens expressed in thymus for T cells and bone marrow for B lymphocytes
- Self-reactive lymphocytes complete their maturation → Peripheral tolerance
● Central Tolerance occurs during stage in maturation of lymphocytes when
encounter with antigen may lead to cell death or replacement of self-reactive
antigen receptor with one that is not self-reactive
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
6. Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
7. Overview
● Mature lymphocytes that recognize self antigens in peripheral tissues become
incapable of activation by re-exposure to that antigen or die by apoptosis
Important mechanism for the induction of peripheral tolerance = Antigen recognition
without costimulation or “second signals”
● Peripheral tolerance maintained by regulatory T cells (Tregs) that actively
suppress activation of lymphocytes
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
8. Overview
● Some self antigens are sequestered from immune system, and other antigens are
ignored
Antigens may be sequestered from the immune system by anatomic barriers, such as
in the testes and eyes → cannot engage antigen receptors
● Induction of immunologic tolerance - possible therapeutic strategy for preventing
harmful immune responses.
There is great interest in inducing tolerance to treat autoimmune and allergic diseases
and to prevent the rejection of organ transplants
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
10. T Lymphocyte Tolerance
● Central T cell Tolerance
● Peripheral T cell Tolerance
● Factor that Determine the Tolerogenicity of Self Antigens
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
11. Central T Cell Tolerance
● During their maturation in thymus, many immature T cells that recognize antigens with
high avidity die, and some of surviving cells in the CD4+ lineage develop into Tregs
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
12. Central T Cell Tolerance
● Thymus has special mechanism for expressing many protein antigens expressed in
different peripheral tissues, produced in medullary thymic epithelial cells (MTECs)
under the control of the autoimmune regulator (AIRE) protein, immature T cells specific
for these antigens can be deleted
● Mutations in the AIRE gene are the cause of a multi-organ autoimmune disease,
autoimmune polyendocrine syndrome type 1 (APS1) characterized by antibody- and
lymphocyte-mediated injury to multiple endocrine organs; parathyroids, adrenals, and
pancreatic islets
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
13. Central T Cell Tolerance
● In the absence of functional AIRE,
these antigens are not displayed in
the thymus, and T cells specific for
the antigens escape deletion, mature,
and enter the periphery → attack
target tissues
● Patients with AIRE mutations also
make neutralizing autoantibodies
against their own IL-17
● Deficiency of IL-17 → patients
susceptible to mucocutaneous
candidiasis
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
14. Central T Cell Tolerance
● Regulatory cells leave the thymus and inhibit responses against self antigens in the
periphery
● Determination of deletion OR development of Tregs
- Affinity of antigen recognition
- Types of antigen presenting cells (APCs) presenting antigen
- Availability of cytokines in thymus
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
15. Peripheral T Cell Tolerance
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
17. Peripheral T Cell Tolerance
Anergy (Functional Unresponsiveness)
● Exposure of mature CD4+ T cells to
antigen in absence of costimulation
or innate immunity may make the
cells incapable of responding to that
antigen
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
18. Mechanisms induce and maintain anergic
state
• TCR-induced signal transduction is blocked
in anergic cells
• Self antigen recognition may activate cellular
ubiquitin ligases → ubiquitinate TCR-associated
proteins and target them for proteolytic
degradation in proteasomes or lysosomes
• T cells recognize self antigens, they engage
inhibitory receptors of CD28 family, whose
function is to terminate T cell responses
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
Peripheral T Cell Tolerance
19. Peripheral T Cell Tolerance
Regulation of T Cell Responses by Inhibitory Receptors
● Inhibitory receptors: CTLA-4 and PD-1
CTLA-4 (cytotoxic T lymphocyte antigen-4): member of CD28 receptor family, like the
activating receptor CD28, it binds to B7 molecules
● People with mutations in CTLA4 gene develop inflammatory lesions containing
activated T cells and macrophages affecting multiple organs
● Polymorphisms in CTLA4 gene are associated with several autoimmune diseases in
humans, including type 1 diabetes and Graves’ disease
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
20.
21. Peripheral T Cell Tolerance
CTLA-4 inhibits T cell activation in 2
different ways:
● Cell-intrinsic mechanism, upon
activation, responding T cells begin
to express CTLA-4 and shuts off
further activation → terminate
response
● Cell-extrinsic pathway, Tregs
express high CTLA-4 and prevent
activation of responding cells
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
22. Peripheral T Cell Tolerance
● CTLA-4 functions as competitive
inhibitor of CD28 and reduces the
availability of B7 for the CD28
receptor
● CTLA-4 has 10- to 20-fold higher
affinity for B7 than does CD28
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
23. Peripheral T Cell Tolerance
PD-1 (programmed death-1)
● Recognizes 2 ligands: PD-L1 (expressed on
APCs and many other tissue cells) and PD-L2
(expressed mainly on APCs)
● Receptor PD-1 expressed on
antigen-activated T cells
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
24. Peripheral T Cell Tolerance
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
25. Peripheral T Cell Tolerance
Suppression by Regulatory T Cells
● Regulatory T cells are a subset of CD4+ T cells - suppress immune responses
and maintain self-tolerance
- Most of CD4+ Tregs express high levels of interleukin-2 (IL-2) receptor 𝞪 chain
(CD25) and transcription factor called FoxP3
- FoxP3 - member of forkhead family of transcription factors, critical for the
development and function of most Tregs
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
26. Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
27. Peripheral T Cell Tolerance
● Autoimmune disease called IPEX (immune dysregulation, polyendocrinopathy,
enteropathy, X-linked) syndrome caused by mutations in FOXP3 gene and
associated with deficiency of Tregs
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
28. Peripheral T Cell Tolerance
Phenotypic Markers and heterogeneity of Regulatory T Cells
● Regulatory role best established is CD4+ FoxP3+ CD25high
● FoxP3 and CD25 essential for generation, maintenance, and function
● Use IL-2 as their growth and survival factor
● FoxP3+ Tregs typically express high levels of CTLA-4
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
30. Forkhead Winged Transcription Factor, Foxp3
● Mutations diminishing the function of Foxp3 result in loss of the naturally occurring Treg
compartment. Human subjects affected by X-linked autoimmune and allergic
dysregulation syndrome (XLAAD) have significant skewing of patient T lymphocytes
toward the Th2 phenotype
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
31. Forkhead Winged Transcription Factor, Foxp3
● In nTreg cells, FOXP3 can directly interact with Runt-related transcription factor 1
(RUNX1), which impairs expression of IL-2 and IFN-gamma and exerts suppressive
activity
● Induction of RUNX1 and RUNX3 by TGF-b plays an essential role in generation and
suppressive function of induced Treg cells
● RUNX1 and RUNX3 bind to FOXP3 promoter and activate induction of
FOXP3-expressing functional Treg cells
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
32. Generation and Maintenance of Treg Cells
● Tregs are generated mainly by self antigen recognition in thymus and by
recognition of self and foreign antigens in peripheral lymphoid organs
- Thymic regulatory T cells (tTreg), natural Tregs
- In peripheral lymphoid organs, antigen recognition in absence of strong innate
immune responses favors generation of regulatory cells from naive CD4+ T
lymphocytes
- Peripheral regulatory T cells (pTreg), adaptive or inducible Tregs
● Generation of some Tregs requires cytokine transforming growth factor (TGF)-𐌁
TGF-𐌁 stimulates expression of FoxP3
● Survival and functional competence of Tregs dependent on cytokine IL-2
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
33. Generation and Maintenance of Treg Cells
● IL-2 promotes differentiation of T cells into regulatory subset and also required for
maintenance of Treg
● FoxP3+ Tregs do not produce IL-2, this growth factor is provided by conventional T
cells responding to self or foreign antigens
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
34. Generation and Maintenance of Treg Cells
● IL-2 activates transcription factor
STAT5, which enhance expression
of FoxP3 as well as other genes that
are involved in the function of Tregs
● Particular subsets of dendritic cells
may be especially important for
stimulating development of Tregs in
peripheral tissues
● Dendritic cells exposed to retinoic
acid, vitamin A analogue, inducers of
Tregs, especially in mucosal lymphoid
tissues
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
35. Molecular Mechanisms of Treg Cell Generation
● TGF-b contributes to generation of both Th17 and Treg cells
● TGF-b directs peripheral conversion of effector T cells into FOXP3+ Treg cells
● In the presence of IL-6, TGF-b promotes generation of Th17 from naïve T cells
● Retinoic acid also plays a key role in the balance of inflammatory Th17 cells and
suppressive Treg cells by inhibiting the formation of Th17 cells and enhancing the
expression of FOXP3 through STAT3/STAT5 independent signaling pathway
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
36. Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th edition;2018:299-315.
37. Regulation by Regulatory T Cells
Regulatory T cells abundant in GALT and prevent inflammatory reactions against intestinal
commensal microbes
● FOXP3+ Tregs induced in response to antigens encountered locally
● Generation of these peripheral Tregs include local production of retinoic acid and
TGF-beta by CD103+ DCs and lamina propria macrophages -> promote FoxP3
expression and inhibit generation of Th1 and Th2 cells
● Fermentation metabolites, such as short-chain fatty acid butyrate produced by intestinal
commensal bacteria, especially Clostridia species, stimulate peripheral expansion of
thymic Tregs
● Tregs - suppress immune responses by several mechanisms, dominant mechanism in the
gut seems to be production of immunosuppressive cytokine IL-10
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th edition;2018:299-315.
38. Regulation by Regulatory T Cells
● TGF-beta, IL-10, and IL-2 play crucial roles in maintaining homeostasis in gut immune
system
● Deficiencies in these cytokines or their receptors result in pathologic bowel inflammation
● Mice with engineered deficiencies in TGF-beta, IL-10, IL-10 receptor, IL-2, and the IL-2
receptor is uncontrolled bowel inflammation
● Inflammation does not occur in mice raised in germ-free conditions
● Macrophages are another important source of IL-10
● Target cells express receptors for and regulated by TGF-& and IL-10 include DCs, effector
T cells, innate effector cells such as macrophages, and epithelial cells
● Tregs require IL-2 for their maintenance
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th edition;2018:299-315.
39. Mechanisms of Action of Regulatory T Cells
● Suppress immune responses at induction of T cell activation in lymphoid organs and
the effector phase of these responses in tissues
● Directly suppress B cell activation
● Inhibit the proliferation and differentiation of natural killer (NK) cells
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
43. Mechanisms of Action of Regulatory T Cells
• Production of immunosuppressive cytokines
IL-10 and TGF-𐌁
• Reduced ability of APCs to stimulate T cells
by binding of CTLA-4 on Tregs to B7 molecules on
APCs, resulting in competitive inhibition of
CD28-mediated costimulation
• Consumption of IL-2
High level of expression of IL-2 receptor, these cells
absorb IL-2 and deprive other cell populations of this
growth factor, resulting in reduced proliferation and
differentiation of other IL-2–dependent cells
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
44. Inhibitory Cytokines Produced by Treg Cells
TGF-b and IL-10 involved in generation and functions of Tregs
Transforming Growth Factor-b
● TGF-b1 produced by CD4+ Tregs, activated macrophages, and many other cell types
● TGF-b has many important and diverse roles in immune system
● TGF-b inhibits proliferation and effector functions of T cells and activation of
macrophages TGF-b also suppresses the activation of other cells, such as neutrophils
and endothelial cells
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
45. Inhibitory Cytokines Produced by Treg Cells
• TGF-b regulates differentiation of functionally distinct subsets of T cells
- TGF-b stimulates development of peripheral FoxP3+ Tregs
- In combination with IL-1 and IL-6, TGF-b promotes development of Th17 subset of
CD4+ T cells (opposing actions depending on context in which it is produced)
- TGF-b can also inhibit development of Th1 and Th2 subsets
• TGF-b stimulates production of immunoglobulin A (IgA) antibodies by inducing B
cells to switch to this isotype
• TGF-b promotes tissue repair after local immune and inflammatory reactions
subside
- Stimulate collagen synthesis and matrix-modifying enzyme production by
macrophages and fibroblasts and by promoting angiogenesis -> fibrosis and sclerosis
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
46. Inhibitory Cytokines Produced by Treg Cells
Interleukin-10
● IL-10 - inhibitor of activated macrophages and dendritic cells and involved in control of
innate immune reactions and cell-mediated immunity
● IL-10 is produced by many immune cell populations, including activated macrophages
and dendritic cells, Tregs, and Th1 and Th2 cells, some B lymphocytes (regulatory B
cells
● IL-10 inhibits production of IL-12 by activated dendritic cells and macrophages, IL-10
inhibit IFN-gamma production
● IL-10 inhibits expression of costimulators and class II MHC molecules on dendritic cells
and macrophages
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
48. Loss of Suppressive Capacity of Treg Cells
During Inflammatory Responses
● Strong proinflammatory signals lead to loss of Treg function
● Activation of DC through TLR leads to production of signals, including IL-6, which block
the suppressive effect of CD4+CD25+ Treg cells
● IL-6 can promote disease via 2 mechanisms: directly enhancing Th2 responses and
overcoming suppressive function of CD4+CD25+ Treg cells
● TNF-alpha as well as IL-7 and IL-15 also overcome regulatory activity
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
49. Deletion of T Cells by Apoptotic Cell Death
● T lymphocytes that recognize self antigens with high affinity or are repeatedly
stimulated by antigens may die by apoptosis
● 2 major pathways of apoptosis, peripheral deletion of mature T cells:
- Mitochondrial (or intrinsic) pathway
- Death receptor (or extrinsic) pathway
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
50.
51. Deletion of T Cells by Apoptotic Cell Death
These 2 death pathways may function in different ways to maintain self-tolerance
● T cells that recognize self antigens in absence of costimulation may activate Bim,
resulting in apoptosis by mitochondrial pathway
● In normal immune responses, responding lymphocytes receive signals from TCR,
costimulators, and growth factors
● These signals stimulate expression of because of relative lack of costimulation and
growth factors, anti-apoptotic members of Bcl-2 family, Bcl-2 and Bcl-XL, are expressed
at low levels, and actions of Bim, Bax, and Bak are thus not counteracted
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
52. Deletion of T Cells by Apoptotic Cell Death
● Repeated stimulation of T cells results in coexpression of death receptor Fas and its
ligand Fas-L, and engagement of Fas triggers apoptotic death
● When T cells repeatedly activated, FasL is expressed on cell surface, and it binds to
surface Fas on the same or adjacent T cells → activates cascade of caspases, which
ultimately cause apoptotic death
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
53. Factors Determine Tolerogenicity of Self
Antigens
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
54. Factors Determine Tolerogenicity of Self
Antigens
● Tissue dendritic cells - normally in a resting (immature) state and express low levels of
costimulators; constantly presenting self antigens without providing strong
costimulation, and T cells that recognize these antigens become anergic or differentiate
into regulatory T lymphocytes instead of effector and memory lymphocytes
● By contrast, dendritic cells activated by microbes are the principal APCs for initiating T
cell responses
● Local infections and inflammation may activate resident dendritic cells, leading to
increased expression of costimulators, breakdown of tolerance, and autoimmune
reactions
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
56. B Lymphocyte Tolerance
- Maintaining unresponsiveness to thymus-independent self antigens, such as
polysaccharides and lipids
- Preventing antibody responses to protein antigens
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
57. Central B Cell Tolerance
Immature B lymphocytes that recognize self antigens in the bone marrow with high
affinity change their specificity or are deleted
Receptor editing
● B cells reactivate their RAG1 and RAG2 genes and initiate new round of VJ
recombination in the Ig kappa light chain gene locus
● Previously rearranged V kappa J kappa exon in self-reactive immature B cell is deleted,
and new Ig light chain is expressed, thus creating BCR with new specificity
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
58. Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
59. Central B Cell Tolerance
Deletion
● If editing fails, immature B cells may die by apoptosis
Anergy
● If developing B cells recognize self antigens weakly (e.g., if the antigen is soluble and
does not cross-link many antigen receptors or if the BCRs recognize the antigen with
low affinity), cells become functionally unresponsive (anergic) and exit bone marrow in
unresponsive state
● Anergy is due to downregulation of antigen receptor expression and a block in antigen
receptor signaling.
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
60. Peripheral B Cell Tolerance
Mature B lymphocytes that recognize self antigens in peripheral tissues in absence of
specific helper T cells may be rendered functionally unresponsive or die by apoptosis
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
61. Peripheral B Cell Tolerance
● Signals from helper T cells may be absent if these T cells are deleted or anergic or if
the self antigens are non-protein antigens
● As in T cells, antigen recognition without additional stimuli results in tolerance
Anergy and deletion
● Some self-reactive B cells that are repeatedly stimulated by self antigens become
unresponsive
● Require higher than normal levels of the growth factor BAFF for survival
● Have shortened life span
● B cells that bind with high avidity to self antigens in periphery may also undergo
apoptotic death by mitochondrial pathway
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
62. Peripheral B Cell Tolerance
Signaling by inhibitory receptors
● Immunoreceptor tyrosine-based activation motifs (ITIMs) in cytoplasmic tail of CD22 are
phosphorylated by Lyn, and this inhibitory receptor then recruits SHP-1, thus
attenuating B cell receptor signaling
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
63. Tolerance to Commensal Microbes
● Commensal microbes - abundant in the gut, skin, and other tissues but do not elicit
immune responses despite being foreign
● Many of these microbes cannot invade epithelial barriers and not accessible to
adaptive immune system
● Commensal microbes elicit little or no innate immunity and thus fail to induce
costimulators and other signals that are required for effective adaptive immune
responses
● Also induce and activate Tregs
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
64. Tolerance to Other Foreign Antigens
● Protein antigens administered with adjuvants favor immunity
● Repeated doses of antigens administered without adjuvants tend to induce tolerance
(adjuvants stimulate innate immune responses and expression of costimulators on
APCs)
● Oral administration of protein antigen often leads to suppression of systemic humoral
and cell-mediated immune responses to immunization with the same antigen = oral
tolerance
Abul K. Abbas, et al. Cellular and Molecular Immunology. 9th Edition;2018:325-350.
67. Treg Cells in Allergen-Specific Immunotherapy
● Healthy and allergic individuals exhibit all Th1, Th2, and Treg cells subsets but in
different proportions
● Healthy individuals, IL-10–secreting Tr1 or IL-10-Treg cells are dominant subset for
common environmental allergens
● Allergic individuals allergen-specific IL-4 secreting T cells (Th2-like) exist in high
frequency
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
68. AIT and Treg Cells Influence Allergen-Specific
Antibody Responses
● Balance between Th2 cells and Treg cells is decisive for induction and maintenance of
this tolerance status
● AIT often induces transient increase in serum-specific IgE followed by gradual decrease
over months or years
● Changes in IgE levels cannot account forbresponsiveness to specific allergen related to
SIT, because the decrease in serum IgE is late, relatively small, and poorly correlated
with clinical improvement
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
69. AIT and Treg Cells Influence Allergen-Specific
Antibody Responses
● IgG4 believed to capture allergen before reaching effector cell-bound IgE → preventing
activation of mast cells and basophils
● Increases in specific IgG4 levels accompanied clinical improvement
● Venom allergy, rise of antivenom IgG correlates,
● Blocking antibodies seem to inhibit allergen-induced release of inflammatory mediators
from basophils and mast cells, IgE-facilitated allergen presentation to T cells, and
allergen-induced boost of memory IgE production during high allergen exposure in
pollen season
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
71. Involvement of Treg Cells in Suppression of
Effector Cells and Inflammatory Responses
During AIT
● Bronchial, nasal, and conjunctival hyperreactivity to nonspecific stimuli, which seems to
reflect underlying mucosal inflammation, decrease after AIT and correlated with clinical
improvement
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
72. AIT and Treg Cells Influence Allergen-Specific
Antibody Responses
● IL-10 that is induced and increasingly secreted during AIT appears to counter regulate
antigen-specific IgE and IgG4 antibody synthesis
● IL-10 potently suppresses both total and allergen-specific IgE and simultaneously
increases IgG4 production
● IL-10 skews specific response from IgE- to IgG4-dominated phenotype
● With healthy immune response to Der p1, specific IgA and IgG4 increase, IgG1
increases in small amounts, and IgE antibodies in serum almost undetectable
● Increase of specific IgA and IgG4 in serum coincides with increased TGF-b and IL-10,
respectively
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
73. Involvement of Treg Cells in Suppression of
Effector Cells and Inflammatory Responses
During AIT
● Long-term AIT associated with significant reduction of immediate response to allergen
provocation and late phase reaction (LPR) in nasal and bronchial mucosa or skin
● Mechanism of LPR is different from mast cell–mediated immediate reaction and
involves recruitment, activation, and persistence of eosinophils and activation of T cells
at sites of allergen exposure
● Successful AIT results in increase of allergen concentration necessary to induce
immediate or LPR in target tissue and in decreased responses to nonspecific
stimulation
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
74. Involvement of Treg Cells in Suppression of
Effector Cells and Inflammatory Responses
During AIT
● Decreases in IgE antibody levels and IgE-mediated skin sensitivity normally require
several years of SIT, most patients are protected against bee stings at an early stage of
BV-SIT
● Starting with first injection, there is decrease in mast cell and basophil activity for
degranulation and systemic anaphylaxis
● Immuno-silencing of FcεRI-activated basophils by selective suppression of histamine
and sulfido-leukotriene release, as well as cytokine production mediated by histamine
receptor (HR) 2, relevant for very early induction of allergen tolerance and so-called
desensitization effect of VIT
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
75. Involvement of Treg Cells in Suppression of
Effector Cells and Inflammatory Responses
During AIT
● AIT efficiently modulates thresholds for mast cell and basophil activation and decreases
immunoglobulin E-mediated histamine release
● IL-10 reduces proinflammatory cytokine release from mast cells
● IL-10 downregulates eosinophil function and activity and suppresses IL-5 production by
human resting Th0 and Th2 cells
● IL-10 inhibits endogenous GM-CSF production and CD40 expression by activated
eosinophils and enhances eosinophil cell death
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
78. Breg cells and Allergen Tolerance
● IL-10-secreting Breg cells relevant to tolerance (eg. high-dose bee venom–exposed
tolerant bee keepers and subjects receiving bee venom AIT)
● IL-10–secreting Breg cells express high levels of CD25 (IL-2 receptor alpha chain) and
CD71 (transferrin receptor) and express low levels of CD73
● Breg cells express multiple suppressor cytokines and surface molecules, such as IL-10,
TGF-b, IL-35, PDL1, and GARP
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
79. Histamine Receptor 2 as a Major Player in
Peripheral Tolerance
● Histamine regulates several events in the immune response
● During AIT with high allergen doses, histamine released from mast cells and basophils
interferes with peripheral tolerance
● Histamine enhances Th1-type responses by triggering histamine receptor HR1
● HR2 negatively regulates both Th1 and Th2- type responses
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
81. Histamine Receptor 2 as a Major Player in
Peripheral Tolerance
● Histamine induces production of IL-10 by DC
● Histamine induces IL-10 production by Th2 cells and enhances suppressive activity of
TGF-b on T cells mediated via HR2, which is relatively highly expressed on Th2 cells
and suppresses IL-4 and IL-13 production and T cell proliferation
● HR2 may represent essential receptor that participates in peripheral tolerance or active
suppression of inflammatory and immune responses
● Histamine also regulates antibody isotypes including IgE
● Administration of antihistamines decreases HR1/H2R expression ratio, which may
enhance suppressive effect of histamine on T cells
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.
82. Immune Tolerance Induced in SLIT
● IgG4 levels increase but IgE levels remain stable in adults
● Allergen-specific IgA is induced
● Effects of SLIT on T cell reactivity and cytokine secretion vary between studies
● After 6 months of SLIT, ECP and serum IL-13 decreased
● SLIT did reduce need for rescue medication
Mubeccel Akdis, et al. Middleton’s Allergy. 9th Edition;2020:44-64.e1.